Carlos Aracil Blanch

Nicoara-Farcau O; Lozano JJ; Alonso C; Sidorova J; Villanueva C; Albillos A; Genescà J; Llop E; Calleja JL; Aracil C; Bañares R; Morillas R; Poca M; Peñas B; Augustin S; Tantau M; Thompson M; Perez-Campuzano V; Baiges A; Turon F; Hernandez-Gea V; Abraldes JG; Tapias EA; Torres F; Bosch J; Garcia-Pagan JC

Metabolomics as a tool to predict the risk of decompensation or liver related death in patients with compensated cirrhosis.

Hepatology 77 2052-2062. 01/06/2023.

[doi:10.1097/HEP.0000000000000316]

Bassegoda O; Rivera-Esteban J; Serra I; Morillas R; Broquetas T; Vergara M; Rodriguez A; Aracil C; Virolés S; Carrión JA; Pardo A; Rodríguez-Tajes S; Serra-Burriel M; Pericàs JM; Augustin S; Ginès P; Graupera I

High frequency of acute decompensation and cancer in patients with compensated cirrhosis due to nonalcoholic fatty liver disease: A retrospective cohort study.

Hepatology Communications 6 3212-3222. 01/11/2022.

[doi:10.1002/hep4.2056]

Sanchez-Aldehuelo, R; Villanueva, C; Genesca, J; Pagan, JCG; Brujats, A; Panero, JLC; Aracil, C; Banares, R; Morillas, RM; Poca, M; Penas, B; Augustin, S; Abraldes, J; Alvarado-Tapias, E; Torres, F; Bosch, J; Albillos, A

Worsening of low-grade systemic inflammation heralds decompensation in patients with compensated cirrhosis

JOURNAL OF HEPATOLOGY 77 370-370. 01/07/2022.

Garcia Garcia de Paredes A; Villanueva C; Blanco C; Genescà J; Manicardi N; Garcia-Pagan JC; Calleja JL; Aracil C; Morillas RM; Poca M; Peñas B; Augustin S; Abraldes JG; Alvarado E; Royo F; Garcia-Bermejo ML; Falcon-Perez JM; Bañares R; Bosch J; Gracia-Sancho J; Albillos A

Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis.

JHEP REPORTS 3 100368-100368. 01/12/2021.

[doi:10.1016/j.jhepr.2021.100368]

Villanueva, C; Albillos, A; Genesca, J; Garcia-Pagan, JC; Brujats, A; Calleja, JL; Aracil, C; Bañares R; Morillas, RM; Poca, M; Peñas B; Augustin, S; Abraldes, JG; Alvarado, E; Torres, F; Bosch, J; PreDesCI Study Investigators

Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis.

JOURNAL OF HEPATOLOGY 75 589-599. 01/09/2021.

[doi:10.1016/j.jhep.2021.04.022]

Tapias EA; Ardevol, A; Garcia-Guix, M; Montañés R; Pavel, O; Cuyas, B; Graupera, I; Brujats, A; Vilades, D; Colomo, A; Poca, M; Torras, X; Guarner, C; Concepcion, M; Aracil, C; Torres, F; Villanueva, C

Short-term hemodynamic effects of ß-blockers influence survival of patients with decompensated cirrhosis.

JOURNAL OF HEPATOLOGY 73 829-841. 01/10/2020.

[doi:10.1016/j.jhep.2020.03.048]

Ardevol A; Alvarado-Tapias E; Garcia-Guix M; Brujats A; Gonzalez L; Hernández-Gea V; Aracil C; Pavel O; Cuyas B; Graupera I; Colomo A; Poca M; Torras X; Concepción M; Villanueva C

Early rebleeding increases mortality of variecal bleeders on secondary prophylaxis with ß-blockers and ligation.

Digestive And Liver Disease 52 1017-1025. 01/09/2020.

[doi:10.1016/j.dld.2020.06.005]

Ballester-Clau R; Torres Vicente G; Cucala Ramos M; Aracil Blanch C; Miñana Calafat JM; Pijoan Comas E; Reñé Espinet JM; Planella de Rubinat M

Efficacy and Safety of Treatment With Ferric Carboxymaltose in Patients With Cirrhosis and Gastrointestinal Bleeding.

Frontiers in Medicine 7 128-128. 17/04/2020.

[doi:10.3389/fmed.2020.00128]

Villanueva C; Albillos A; Genescà J; Garcia-Pagan JC; Calleja JL; Aracil C; Bañares R; Morillas RM; Poca M; Peñas B; Augustin S; Abraldes JG; Alvarado E; Torres F; Bosch J

beta blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial

Lancet 393 1597-1608. 20/04/2019.

[doi:10.1016/S0140-6736(18)31875-0]

Ardevol, A; Ibañez-Sanz G; Profitos, J; Aracil, C; Castellvi, JM; Alvarado, E; Cachero, A; Horta, D; Miñana J; Gomez-Pastrana, B; Pavel, O; Dueñas E; Casas, M; Planella, M; Castellote, J; Villanueva, C

Survival of patients with cirrhosis and acute peptic ulcer bleeding compared with variceal bleeding using current first-line therapies

Hepatology 67 1458-1471. 01/04/2018.

[doi:10.1002/hep.29370]

Rodríguez de Lope C; Reig M; Matilla A; Ferrer MT; Dueñas E; Mínguez B; F Castroagudín J; Ortiz I; Pascual S; Lledó JL; Gallego A; Arenas JI; Aracil C; Forne M; Muñoz C; Pons F; Sala M; Iñarrairaegui M; Martin-Llahi M; Andreu V; Garre C; Rendón P; Fuentes J; Crespo J; Rodríguez M; Bruix J; Varela M

Clinical characteristics of hepatocellular carcinoma in Spain. Comparison with the 2008-2009 period and analysis of the causes of diagnosis out of screening programs. Analysis of 686 cases in 73 centers

MEDICINA CLINICA 149 61-71. 01/07/2017.

[doi:10.1016/j.medcli.2016.12.048]

Villanueva, C; Graupera, I; Aracil, C; Alvarado, E; Minana, J; Puente, A; Hernandez-Gea, V; Ardevol, A; Pavel, O; Colomo, A; Concepcion, M; Poca, M; Torras, X; Rene, JM; Guarner, C

A Randomized Trial to Assess Whether Portal Pressure Guided Therapy to Prevent Variceal Rebleeding Improves Survival in Cirrhosis

Hepatology 65 1693-1707. 01/05/2017.

[doi:10.1002/hep.29056]